Distinguished Toronto Scientist Dr. Jim Woodgett Takes Up Leadership of Terry Fox Research Institute on August 1
The Board of Directors of the Terry Fox Research Institute (TFRI) has announced the appointment of Jim Woodgett, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI), part of Sinai Health in Toronto, as its new President and Scientific Director effective Aug. 1.
“Dr. Woodgett is an accomplished research leader and senior scientist with a track record for excellence and collaboration over several decades,” says Dr. Christopher Paige, Chair of the TFRI Board of Directors. “We are confident he is the right choice to captain our research endeavour and take us to the next level as we navigate new horizons with existing and new partners across the country -- and beyond -- in our shared vision to work together to accelerate precision medicine for Canadians.”
Dr. Woodgett succeeds TFRI’s founding president Dr. Victor Ling, O.C., O.B.C., PhD who has led the Institute since its creation in 2007. He will head TFRI as it is on the cusp of implementing two novel pan-Canadian projects that will change the future of cancer research and care in Canada: the Marathon of Hope Cancer Centres Network (MOHCCN) and the Digital Health and Discovery Platform (DHDP).
"I look forward to building on Dr. Vic Ling’s exemplary leadership and initiative in driving forward the enduring and inspirational vision of Terry Fox by bringing Canada's best scientific minds together to control and find cures for the scourge of cancer,” says Dr. Woodgett.
Read more about Dr. Woodgett and his appointment: https://bit.ly/2TU5K4s